US Federal 2025-2026 Regular Session

US Federal House Bill HB4564

Introduced
7/21/25  

Caption

Dillon’s Law

Impact

If passed, HB 4564 would enhance the legal framework supporting asthma treatment in schools by broadening the definition of who can administer critical medications. This change is intended to provide states with an incentive to allow non-employee trained personnel, such as volunteers or parents, to assist in administering life-saving treatments. By doing so, the bill aims to reduce barriers that might prevent children from receiving immediate help during medical emergencies related to asthma or severe allergies.

Summary

House Bill 4564, titled 'Dillon’s Law', seeks to amend the Public Health Service Act with a focus on improving the administration of asthma treatment in schools. The bill proposes to create a special rule that would allow trained individuals who are not school employees to be considered part of the school’s trained personnel. This is aimed particularly at facilitating the administration of epinephrine to students who may require it due to severe allergic reactions. The legislation emphasizes the importance of ensuring that children in schools have access to necessary medical interventions in a timely manner.

Contention

Notably, the bill may provoke discussions regarding the qualifications and training required for individuals administering epinephrine. There could be concerns about ensuring that these trained individuals have adequate medical knowledge and skills necessary to handle potential emergencies. As schools work to ensure safety and compliance with health regulations, there may be debate about the balance between increasing access to treatment and maintaining rigorous training standards for personnel involved in student health care.

Companion Bills

No companion bills found.

Previously Filed As

US HB2462

DILLON’S LAW

US HB339

School districts; require all schools to have epinephrine auto-injectors in every building and cafeteria.

US HB5278

Affordable Inhalers and Nebulizers Act of 2025

US H7896

Permits students diagnosed with asthma, a condition that may lead to bronchospasm or anaphylaxis, or both, to carry and self-administer asthma medication or auto-injectable or intranasal epinephrine, or both.

US S2855

Permits students diagnosed with asthma, a condition that may lead to bronchospasm or anaphylaxis, or both, to carry and self-administer asthma medication or auto-injectable or intranasal epinephrine, or both.

US H2526

Relative to the provision and administration of bronchodilators, spacers, and nebulizers in schools

US SB568

Pupil health: epinephrine delivery systems: schoolsites and childcare programs.

US H2520

Relative to improving asthma in schools

US HB2250

Permitting the use of expedited partner therapy to treat sexually transmitted infections, authorizing a licensed private psychiatric hospital to maintain a stock supply of emergency medication kits for pharmaceutical emergencies, allowing expired emergency opioid antagonists to be used to treat an opioid overdose, permitting first responders to distribute and administer expired emergency opioid antagonists, permitting a pharmacist to distribute epinephrine delivery systems to a school for use in emergency medication kits and amending definitions related to medication in schools to allow for use of epinephrine delivery systems.

US SB1

Relating to the administration of epinephrine.

Similar Bills

No similar bills found.